Levodopa for Parkinson's Disease

TS
Overseen ByTrisha S Pasricha, MD, MPH
Age: Any Age
Sex: Any
Trial Phase: Phase 4
Sponsor: Beth Israel Deaconess Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

The main treatment for Parkinson's disease is a medication called levodopa. Levodopa has to be absorbed from the gut and travel to the brain to work, but a naturally occurring enzyme in the lining of the stomach, called dopamine decarboxylase (AADC), can break some of it down before it ever reaches the brain. We do not yet know whether people whose stomachs have more of this enzyme absorb less of their levodopa dose, have worsened gastrointestinal (GI) symptoms associated with levodopa intake, and whether that affects how well the medication controls their movement symptoms. This research may help doctors understand why levodopa works better in some people with Parkinson's disease than others, which could help improve treatment in future.

Are You a Good Fit for This Trial?

This trial is for people diagnosed with Parkinson's disease who are taking levodopa as part of their treatment. Specific inclusion or exclusion criteria are not listed, but participants should be able to take levodopa and undergo study procedures.

Inclusion Criteria

I have had stomach biopsies taken during an endoscopy.
I have been diagnosed with Parkinson's disease.
I am currently taking dopamine replacement medication.

Exclusion Criteria

I do not have a history of Parkinson's disease.

What Are the Treatments Tested in This Trial?

Interventions

  • Levodopa

Trial Overview

The study looks at how the enzyme dopamine decarboxylase in the stomach affects how much levodopa gets absorbed and works in people with Parkinson's disease. Researchers will measure drug levels and symptoms after taking levodopa.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Group I: Non-elevated AADCExperimental Treatment1 Intervention
Group II: Elevated AADCExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Beth Israel Deaconess Medical Center

Lead Sponsor

Trials
872
Recruited
12,930,000+

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Trials
2,513
Recruited
4,366,000+